PEXA AB PExA AB has filed an IPO.
PExA AB has filed an IPO.
September 14, 2015 at 12:00 am EDT
Share
Share
© S&P Capital IQ - 2015
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.378 SEK | -1.31% |
|
+1.61% | -8.70% |
| Feb. 21 | PExA AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
| Feb. 21 | PExA AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The instrument provides lung researchers with a non-invasive method for collecting microscopic particles, potential biomarkers for diseases, from small airways in exhaled air to diagnose, monitor and provide treatment of respiratory diseases.
Calendar
2024-08-19
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -8.70% | 1.51M | |
| -18.97% | 18.12B | |
| -42.48% | 2.87B | |
| +22.69% | 1.9B | |
| -1.56% | 1.65B | |
| +32.98% | 1.34B | |
| -17.41% | 957M | |
| -22.25% | 896M | |
| +10.31% | 841M | |
| -26.78% | 612M |
- Stock Market
- Equities
- PEXA B Stock
- News PExA AB
- PExA AB has filed an IPO.